Identification of Pathways and Targets in Post-influenza Invasive Pulmonary Aspergillosis
流感后侵袭性肺曲霉病的途径和靶标的确定
基本信息
- 批准号:10224339
- 负责人:
- 金额:$ 6.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAllergic Bronchopulmonary AspergillosisAntiviral AgentsArchitectureAspergillosisAspergillusAspergillus fumigatusBacterial PneumoniaCell physiologyCellsCellular AssayCessation of lifeClinicalCritical IllnessDNA Sequencing FacilityDataDevelopmentDiseaseFutureGenesGenomicsGoalsHealthHematopoietic Stem Cell TransplantationHeterogeneityHost DefenseHumanImmuneImmune TargetingImmune responseImmune systemImmunocompromised HostIndividualInfectionInflammationInfluenzaInfluenza A virusInhalationInheritedInterferonsInvadedInvestigationKnowledgeLaboratoriesLearningLeukocytesLifeLungLung TransplantationLung infectionsMapsMethodsModelingMolecularMorbidity - disease rateMusMycosesNeutropeniaPTPRC genePathway interactionsPatientsPlayPopulationPredispositionPreparationRegulator GenesReproduction sporesResearchResearch Project GrantsResearch SupportResolutionRespiratory SystemRespiratory Tract InfectionsRiskRisk FactorsSamplingSecondary toSignal PathwaySignal TransductionStructure of parenchyma of lungTherapeutic InterventionUniversitiesacquired immunodeficiencybasecell typeexperienceexperimental studyfungusinflammatory milieuinfluenza epidemicinfluenza infectionmortalitymouse modelnovel therapeutic interventionpathogenic funguspreventrespiratoryresponsesingle cell sequencingsingle-cell RNA sequencingsuperinfectiontranscriptometranscriptomics
项目摘要
PROJECT SUMMARY
Fungal pathogens are a serious threat to human health. Invasive pulmonary aspergillosis (IPA) is a severe, life-
threatening disease that occurs when Aspergillus fumigatus (AF) spores are inhaled into the respiratory tract
and invade airway or lung tissue. More than 200,000 cases of invasive aspergillosis occur each year. A newly
identified risk factor for IPA in critically ill patients is influenza infection. Influenza is a common respiratory illness
that affects 5-20% of the population each year. Our long-term goal is to develop novel therapeutic interventions
for use in clinical settings to prevent morbidity and mortality from IPA. The focus of this application is to identify
cell signaling pathways that increase susceptibility to invasive fungal disease following influenza infection. We
hypothesize that preceding influenza A infection inhibits leukocyte responses against secondary Aspergillus
fumigatus infection through the induction of IFN, leading to invasive pulmonary aspergillosis. Our research aims
include 1) To characterize the gene regulatory architecture of leukocytes at a single cell resolution during post-
influenza invasive pulmonary aspergillosis. We will perform single cell RNA sequencing on CD45+ immune cells
collected from lung tissue from (1) wild-type and (2) IFN -/- mice infected with aspergillus, influenza, and super-
infected with influenza followed by aspergillus.
项目概要
真菌病原体对人类健康构成严重威胁。
当烟曲霉 (AF) 孢子被吸入呼吸道时发生的威胁性疾病
每年发生超过20万例侵袭性曲霉菌病。
已确定重症患者发生 IPA 的危险因素是流感感染,流感是一种常见的呼吸道疾病。
每年影响 5-20% 的人口,我们的长期目标是开发新的治疗干预措施。
用于临床环境中预防 IPA 的发病率和死亡率 该应用的重点是确定。
流感感染后增加对侵袭性真菌病易感性的细胞信号传导途径。
在此之前的甲型流感感染抑制白细胞针对继发曲霉的反应
我们的研究目的是通过诱导 IFNα 来感染烟曲菌,从而导致侵袭性肺曲霉病。
包括 1) 以单细胞分辨率表征白细胞的基因调控结构。
我们将对 CD45+ 免疫细胞进行单细胞 RNA 测序。
从 (1) 野生型和 (2) IFN-/- 感染曲霉、流感和超级小鼠的肺组织中收集
感染流感,随后感染曲霉菌。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Keven Mara Robinson其他文献
Keven Mara Robinson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Keven Mara Robinson', 18)}}的其他基金
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
流感削弱肺宿主对侵袭性肺曲霉病的先天防御
- 批准号:
10835161 - 财政年份:2021
- 资助金额:
$ 6.81万 - 项目类别:
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
流感削弱肺宿主对侵袭性肺曲霉病的先天防御
- 批准号:
10449394 - 财政年份:2021
- 资助金额:
$ 6.81万 - 项目类别:
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
流感削弱肺宿主对侵袭性肺曲霉病的先天防御
- 批准号:
10651832 - 财政年份:2021
- 资助金额:
$ 6.81万 - 项目类别:
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
流感削弱肺宿主对侵袭性肺曲霉病的先天防御
- 批准号:
10297248 - 财政年份:2021
- 资助金额:
$ 6.81万 - 项目类别:
Identification of Pathways and Targets in Post-influenza Invasive Pulmonary Aspergillosis
流感后侵袭性肺曲霉病的途径和靶标的确定
- 批准号:
10063634 - 财政年份:2020
- 资助金额:
$ 6.81万 - 项目类别:
Role of IL-33 in Influenza and Staphylococcus aureus Co-infection
IL-33 在流感和金黄色葡萄球菌合并感染中的作用
- 批准号:
9320979 - 财政年份:2016
- 资助金额:
$ 6.81万 - 项目类别:
Role of IL-33 in Influenza and Staphylococcus aureus Co-infection
IL-33 在流感和金黄色葡萄球菌合并感染中的作用
- 批准号:
9751941 - 财政年份:2016
- 资助金额:
$ 6.81万 - 项目类别:
相似海外基金
The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity
SARS-CoV-2 免疫失调对抗真菌免疫的影响
- 批准号:
10658355 - 财政年份:2023
- 资助金额:
$ 6.81万 - 项目类别:
Mechanistic Investigation of Gut Mycobiota in the Regulation of Lung Immunity and Disease
肠道菌群调节肺部免疫和疾病的机制研究
- 批准号:
10793853 - 财政年份:2023
- 资助金额:
$ 6.81万 - 项目类别:
Genetic Determinants of Aspergillus host-pathogen interactions
曲霉菌宿主-病原体相互作用的遗传决定因素
- 批准号:
10724816 - 财政年份:2023
- 资助金额:
$ 6.81万 - 项目类别:
Lymph node stromal cells coordinate immune cell environments during Aspergillus fumigatus infection
烟曲霉感染期间淋巴结基质细胞协调免疫细胞环境
- 批准号:
10751936 - 财政年份:2023
- 资助金额:
$ 6.81万 - 项目类别:
Development of a novel broad spectrum antifungal therapeutic targeting Glycosylphosphatidylinositol (GPI) biosynthesis and cell wall biogenesis
开发一种针对糖基磷脂酰肌醇 (GPI) 生物合成和细胞壁生物合成的新型广谱抗真菌治疗药物
- 批准号:
10759723 - 财政年份:2023
- 资助金额:
$ 6.81万 - 项目类别: